Loading
Latest filing published 07 Nov 2023 for Theseus Pharmaceuticals, Inc., €75k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of William Shakespeare in Theseus Pharmaceuticals, Inc. In total, 2 filings cover trades dated from 12 October 2021 to 6 November 2023.
On the market, this insider has only ever bought: 1 purchase, €8,670 in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 1 option exercise.
The newest entry dates from 7 November 2023: an option exercise of €75k, in Theseus Pharmaceuticals, Inc. The most recent open-market purchase was published on 14 October 2021, 1,836 days ago. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations